Approval · Notice of Compliance 417 · 2002
MD-60: Notice of Compliance 417
Issued August 1, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 417
- Date
- August 1, 2002
- Company
- Tyco HealthcarePointe-Claire, Quebec, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Intravascular x-ray contrast medium-md-60, ionic, water soluble radiopaque contrast medium for intravascular use-md-76
Products in this notice
Medicinal ingredients
- DIATRIZOATE SODIUM 80 MG per ML
- DIATRIZOATE MEGLUMINE 520 MG per ML
- DIATRIZOATE SODIUM 100 MG per ML
- DIATRIZOATE MEGLUMINE 660 MG per ML